Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-01

Clinical Trial Update: PROfiling Based Endometrial Cancer Adjuvant Therapy [NA]

View source ↗

Summary

A clinical trial evaluating profiling-based adjuvant therapy for endometrial cancer is currently recruiting for stage I and stage II disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: Endometrial Cancer Stage I, Endometrial Cancer Stage II | NA | Status: RECRUITING